Erratum to "Infection in fracture fixation: From basic research, to diagnosis, to evidence-based treatment" [Injury 37 (Suppl. 2)] (DOI:10.1016/j.injury.2006.04.005);State of the knowledge of bacterial resistance

Injury

Volumn 37, Issue 2 SUPPL., 2006, Pages

  Berger Bächi, Brigitte ^a   McCallum, Nadine ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Antibiotic resistance mechanisms; Five silly trailers; Staphylococcus aureus.

Indexed keywords

GLYCOPEPTIDE; KETOLIDE; LINCOSAMIDE DERIVATIVE; LINEZOLID; MACROLIDE; METICILLIN; OXAZOLIDINONE DERIVATIVE; STREPTOGRAMIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GENETICS; BACTERIAL GROWTH; BACTERIUM ISOLATE; DNA REPLICATION; DNA TRANSCRIPTION; DRUG EFFICACY; GENE MUTATION; GENE TRANSFER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; INFECTION SENSITIVITY; MOLECULAR EVOLUTION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

EID: 33646140798     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0020-1383(06)00109-4     Document Type: Erratum

References (37)

1. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus. A new model of antibiotic resistance. Lancet Infect Dis 1 3 (2001) 147-155
2. Sieradzki K., Leski T., Dick J., et al. Evolution of a vancomycin- intermediate Staphylococcus aureus strain in vivo: multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotics administered for therapy. J Clin Microbiol 41 4 (2003) 1687-1693
3. Hooper D.C. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect. Dis 2 9 (2002) 530-538
4. Chopra I., O'Neill A.J., and Miller K. The role of mutators in the emergence of antibiotic-resistant bacteria. Drug Resist Updat 6 3 (2003) 137-145
5. Prunier A.L., Malbruny B., Laurans M., et al. High rate of macrolide resistance in Staphylococcus aureus strains from patients with cystic fibrosis reveals high proportions of hypermutable strains. J Infect Dis 187 11 (2003) 1709-1716
6. Leclercq R. Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34 4 (2002) 482-492
7. Perichon B., and Courvalin P. Update on vancomycin resistance. Int J Pract 54 4 (2000) 250-254
8. Baptista M., Depardieu F., Reynolds P., et al. Mutations leading to increased levels of resistance to glycopeptide antibiotics in VanB-type enterococci. Mol Microbiol 25 1 (1997) 93-105
9. Martin J.F., Casqueiro J., and Liras P. Secretion systems for secondary metabolites: how porducer cells send out messages of intercellular communication. Curr Opin Microbiol 8 3 (2005) 282-293
10. Osborn A.M., and Böltner D. When phage, plasmids, and transposons collide: genomic islands, and conjugative- and mobilizable-transposons as a mosaic continuum. Plasmid 48 3 (2002) 202-212
11. Courvalin P. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob Agents Chemother 38 7 (1994) 1147-1451
12. Hakenbeck R. Transformation in Streptococcus pneumoniae: mosaic genes and the regulation of competence. Res Microbiol 151 6 (2000) 453-546
13. Stewart P.S., and Costerton J.W. Antibiotic resistance of bacteria in biofilms. Lancet 358 9276 (2001) 135-138
14. Mateus C., Crow Jr. S.A., and Ahearn D.G. Adherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazole. Antimicrob Agents Chemother 48 9 (2004) 3358-3366
15. Proctor R.A., Balwit J.M., and Vesga O. Variant subpopulations of Staphylococus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3 6 (1994) 302-312
16. Baumert N., von Eiff C., Schaaff F., et al. Physiology and antibiotic susceptibility of Staphylococcus aureus small colony variants. Microb Drug Resist 8 4 (2002) 253-260
17. Bush K., Jacoby G.A., and Medeiros A.A. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 39 6 (1995) 1211-1233
18. Hakenbeck R., and Coyette J. Resistant penicillin-binding proteins. Cell Mol Life Sci 54 4 (1998) 332-340
19. Chambers H.F. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis 7 2 (2001) 178-182
20. Zetola N., Francis J.S., Nuermberger E.L., et al. Community- acquired meticillin-resistant Staphylococus aureus: an emerging threat. Lancet Infect Dis 5 5 (2005) 275-286
21. Ito T., Okuma K., Ma X.X., et al. Insights on antibiotic resistance of Staphylococcus aureus from its whole genome: genomic island SCC. Drug Res Updat 6 1 (2003) 41-52
22. Robinson D.A., and Enright M.C. Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect 10 2 (2004) 92-97
23. Berger-Bächi B., and Rohrer S. Factors influencing methicillin resistance in staphylococci. Arch Microbiol 178 3 (2002) 165-171
24. Safo M.K., Zhao Q., Ko T.P., et al. Crystal structures of the BlaI repressor from Staphylococcus aureus and its complex with DNA: insights into transcriptional regulation of the bla and mec operons. J Bacteriol 187 5 (2005) 1833-1844
25. Ender M., McCallum N., Adhikari R., et al. Fitness cost of SCCmec and methicillin resistance levels in Staphylococcus aureus. Antimcrob Agents Chemother 48 6 (2004) 2295-2297
26. Ruef C. Epidemiology and clinical impact of glycopeptide resistance in Staphylococcus aureus. Infection 32 6 (2004) 315-327
27. Boyle-Vavra S., Berke S.K., Lee J.C., et al. Reversion of the glycopeptide resistance penotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 44 2 (2000) 272-277
28. Noble W.C., Virani Z., and Cree R.G. Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. FEMS Microbiol Lett 72 2 (1992) 195-198
29. Courvalin P. Genetics of glycopeptide resistance in gram-positive pathogens. Int J Med Microbiol 294 8 (2005) 479-486
30. Hancock R.E. Mechanisms of action of newer anti-biotics for Gram-positive pathogens. Lancet Infect Dis 5 4 (2005) 209-218
31. Shinabarger D. Mechanism of action of the oxazolidinone antibacterial agents. Expert Opin Investig Drugs 8 8 (1999) 1195-1202
32. Sander P., Belova L., Kidan Y.G., et al. Ribosomal and non-ribosomal resistance to oxazolidinones: species-specific idiosyncrasy of ribosomal alterations. Mol Microbiol 46 5 (2002) 1295-1304
33. Tsiodras S., Gold H.S., Sakoulas G., et al. Linezolid resistance in a clinical isolate of Staphylococus aureus. Lancet 358 9277 (2001) 207-208
34. Pillai S.K., Sakoulas G., Wennersten C., et al. Linezolid resistance in Staphylococcus aureus: Characterization and stability of resistant phenotype. J Infect Dis 186 11 (2002) 1603-1607
35. Roberts M.C., Sutcliffe J., Courvalin P., et al. Nomenclature for macrolide and macrolide-lincosamide-streptograminB resistance determinants. Antimicrob Agents Chemother 43 12 (1999) 2823-2830
36. Liu M., and Douthwaite S. Activity of the ketolide telithromycin is refractory to Erm monomethylation of bacterial rRNA. Antimcrob Agents Chemother 46 6 (2002) 1629-1633
37. Garza-Ramos G., Xiong L., Zhong P., et al. Binding site of macrolide antibiobiotics on the ribosome: New resistance mutation identifies a specific interaction of ketolides with rRNA. J Bacteriol 183 23 (2001) 6898-6907